1. Home
  2. CNVS vs VNRX Comparison

CNVS vs VNRX Comparison

Compare CNVS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNVS
  • VNRX
  • Stock Information
  • Founded
  • CNVS 2000
  • VNRX N/A
  • Country
  • CNVS United States
  • VNRX United States
  • Employees
  • CNVS N/A
  • VNRX N/A
  • Industry
  • CNVS Consumer Electronics/Video Chains
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CNVS Consumer Discretionary
  • VNRX Health Care
  • Exchange
  • CNVS Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • CNVS 64.1M
  • VNRX 69.7M
  • IPO Year
  • CNVS 2003
  • VNRX N/A
  • Fundamental
  • Price
  • CNVS $2.61
  • VNRX $0.39
  • Analyst Decision
  • CNVS Buy
  • VNRX Strong Buy
  • Analyst Count
  • CNVS 2
  • VNRX 4
  • Target Price
  • CNVS $9.50
  • VNRX $3.50
  • AVG Volume (30 Days)
  • CNVS 111.9K
  • VNRX 1.1M
  • Earning Date
  • CNVS 11-14-2025
  • VNRX 11-14-2025
  • Dividend Yield
  • CNVS N/A
  • VNRX N/A
  • EPS Growth
  • CNVS N/A
  • VNRX N/A
  • EPS
  • CNVS 0.13
  • VNRX N/A
  • Revenue
  • CNVS $80,173,000.00
  • VNRX $1,319,252.00
  • Revenue This Year
  • CNVS N/A
  • VNRX $324.32
  • Revenue Next Year
  • CNVS $36.66
  • VNRX $247.82
  • P/E Ratio
  • CNVS $19.77
  • VNRX N/A
  • Revenue Growth
  • CNVS 77.07
  • VNRX 35.10
  • 52 Week Low
  • CNVS $2.24
  • VNRX $0.39
  • 52 Week High
  • CNVS $7.39
  • VNRX $0.94
  • Technical
  • Relative Strength Index (RSI)
  • CNVS 23.07
  • VNRX 29.55
  • Support Level
  • CNVS $2.85
  • VNRX $0.42
  • Resistance Level
  • CNVS $2.88
  • VNRX $0.48
  • Average True Range (ATR)
  • CNVS 0.15
  • VNRX 0.04
  • MACD
  • CNVS -0.02
  • VNRX 0.00
  • Stochastic Oscillator
  • CNVS 15.17
  • VNRX 2.22

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: